Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24931818)

1.

Response to familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice.

Bell DA, Watts GF.

Clin Cardiol. 2014 Jun;37(6):386-7. doi: 10.1002/clc.22257. Epub 2014 Feb 12. No abstract available.

PMID:
24931818
2.

Familial hypercholesterolemia--we must act boldly.

Moodie D.

Congenit Heart Dis. 2014 Jul-Aug;9(4):273-4. doi: 10.1111/chd.12203. No abstract available.

PMID:
25099345
3.

Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies.

Page MM, Ekinci EI, Jones RM, Angus PW, Gow PJ, O'Brien RC.

Intern Med J. 2014 Jun;44(6):601-4. doi: 10.1111/imj.12444. Review. Erratum in: Intern Med J. 2014 Oct;44(10):1050.

PMID:
24946816
4.

Implementing new guidelines in the management of blood cholesterol.

Boyden TF, Brook RD, Jackson E, Rubenfire M, Eagle K.

Am J Med. 2014 Aug;127(8):705-6. doi: 10.1016/j.amjmed.2014.02.016. Epub 2014 Feb 22. No abstract available.

PMID:
24569024
5.

Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice.

Foody JM.

Clin Cardiol. 2014 Feb;37(2):119-25. doi: 10.1002/clc.22223. Epub 2013 Nov 5. Review.

PMID:
24193792
6.

[Expert consensus on the detection and clinical management of familial hypercholesterolemia].

Masana L, Civeira F, Pedro-Botet J, de Castro I, Pocoví M, Plana N, Mateo-Gallego R, Jarauta E, Pedragosa À.

Clin Investig Arterioscler. 2013 Sep-Oct;25(4):182-93. doi: 10.1016/j.arteri.2013.07.005. Epub 2013 Sep 14. Spanish.

PMID:
24041477
7.

[Dyslipidemia - when are lipid lowering medications useful in clinical practice?].

Blum MR, Stanga Z, Rodondi N.

Praxis (Bern 1994). 2013 May 8;102(10):585-9. doi: 10.1024/1661-8157/a001286. Review. German.

PMID:
23644243
8.

Novel pharmacotherapies of familial hyperlipidemia.

Drakopoulou M, Toutouzas K, Stefanadis C.

Pharmacol Ther. 2013 Sep;139(3):301-12. doi: 10.1016/j.pharmthera.2013.04.012. Epub 2013 Apr 29. Review.

PMID:
23639874
10.

Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.

Rynkiewicz A, Cybulska B, Banach M, Filipiak KJ, Guzik T, Idzior-Waluś B, Imiela J, Jankowski P, Kłosiewicz-Latoszek L, Limon J, Myśliwiec M, Opolski G, Steciwko A, Stępińska J, Zdrojewski T.

Pol Arch Med Wewn. 2013;123(1-2):7-10. No abstract available.

11.

Mipomersen sodium: a new option for the treatment of familial hypercholesterolemia.

Haddley K.

Drugs Today (Barc). 2011 Dec;47(12):891-901. doi: 10.1358/dot.2011.47.12.1722069. Review.

PMID:
22348914
12.

Lomitapide.

[No authors listed]

Am J Cardiovasc Drugs. 2011 Oct 1;11(5):347-52. doi: 10.2165/11533560-000000000-00000. Review.

PMID:
21846156
13.

Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

Robinson JG, Goldberg AC; National Lipid Association Expert Panel on Familial Hypercholesterolemia.

J Clin Lipidol. 2011 Jun;5(3 Suppl):S18-29. doi: 10.1016/j.jacl.2011.03.451. Epub 2011 Apr 3. No abstract available.

PMID:
21600526
14.

A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia.

Davidson MH.

J Clin Lipidol. 2011 Mar-Apr;5(2):76-81. doi: 10.1016/j.jacl.2011.01.005. Epub 2011 Jan 31. Review.

PMID:
21392720
15.
16.

Achieving optimal lipid goals in patients with coronary artery disease.

Karalis DG, Subramanya RD, Hessen SE, Liu L, Victor MF.

Am J Cardiol. 2011 Mar 15;107(6):886-90. doi: 10.1016/j.amjcard.2010.11.006. Epub 2011 Jan 19.

PMID:
21247526
17.

NLA symposium on familial hypercholesterolemia. Question-and-answer session.

McGowan M, Defesche, Whayne T, Tanner JR, Hemphill, Carimi S, Hopkins, Goldberg.

J Clin Lipidol. 2010 Sep-Oct;4(5):357-8. doi: 10.1016/j.jacl.2010.08.017. Epub 2010 Aug 21. No abstract available.

PMID:
21122678
18.

Familial hypercholesterolaemia.

Manning S, Oakeshott P.

Br J Gen Pract. 2009 Dec;59(569):944-5. doi: 10.3399/bjgp09X473213. No abstract available.

19.

Simplifying the approach to the management of dyslipidemia.

Gaziano JM, Gaziano TA.

JAMA. 2009 Nov 18;302(19):2148-9. doi: 10.1001/jama.2009.1685. No abstract available.

PMID:
19920241
20.

ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.

Meuwese MC, de Groot E, Duivenvoorden R, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA; CAPTIVATE Investigators.

JAMA. 2009 Mar 18;301(11):1131-9. doi: 10.1001/jama.301.11.1131.

PMID:
19293413
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk